Results 21 to 30 of about 456,975 (260)

Label-Free Optical Resonator-Based Biosensors

open access: yesSensors, 2020
The demand for biosensor technology has grown drastically over the last few decades, mainly in disease diagnosis, drug development, and environmental health and safety.
Donggee Rho   +2 more
doaj   +1 more source

3D structured biochip for label free determinations at the point-of-need

open access: yesMicro and Nano Engineering, 2022
A novel optical label-free biosensing approach is introduced aiming to remove the current limitations of optical biosensors in their application of on-site food analysis.
G. Zisis   +5 more
doaj   +1 more source

Comparison of a Label-Free Quantitative Proteomic Method Based on Peptide Ion Current Area to the Isotope Coded Affinity Tag Method

open access: yesCancer Informatics, 2008
Recently, several research groups have published methods for the determination of proteomic expression profiling by mass spectrometry without the use of exogenously added stable isotopes or stable isotope dilution theory.
Young Ah Goo   +5 more
doaj   +2 more sources

Label free, quantitative single-cell fate tracking of time-lapse movies

open access: yesMethodsX, 2019
Historically, the ability to perform multi-day time-lapse imaging of adherent cells required expensive and specialized microscopy equipment. As byproduct of this cost, many labs would synchronize cells using inhibitors such as hydroxyurea and thymidine ...
C. Elizabeth Caldon, Andrew Burgess
doaj   +1 more source

Comparison of label‐free and label‐based approaches for surface‐enhanced Raman microscopic imaging of bacteria cells

open access: yesAnalytical Science Advances, 2020
Surface‐enhanced Raman spectroscopic (SERS) approaches are emerging for bacteria analysis whereby bacteria cells can be measured based on their biochemical composition (label‐free) or with the aid of a chemical label to enhance the SERS signal. Combining
Michael E. Hickey, Siyue Gao, Lili He
doaj   +1 more source

Beyond fluorescence: A critical look at AI-powered brightfield analysis for T-cell killing assays

open access: yesSLAS Discovery
This comment evaluates dela Cruz-Chuh et al.’s AI-based label-free workflow for analyzing T-cell mediated tumor killing via brightfield imaging.
Xiaoman Liu, Zihan Gao, Jiachun Xu
doaj   +1 more source

Ovarian Sex Cord Stromal Tumors in Children and Adolescents—The European Standard Clinical Practice Recommendations

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT As part of the European Cooperative Study Group for Paediatric Rare Tumours initiative, we developed standard clinical practice guidelines for ovarian sex cord stromal tumors, based on comprehensive national and international cohort analyses, literature review, and a final expert consensus conference.
Dominik T. Schneider   +15 more
wiley   +1 more source

6. Label-free selective plane illumination microscopy of tissue samples

open access: yesJournal of the Saudi Heart Association, 2017
Basic Science Research. Presentation type: Poster Presentation. Introduction: There is an increasing demand for non-invasive, label-free, three-dimensional imaging techniques for characterisation of optically turbid samples such as tissue engineered ...
Muteb Alharbi   +3 more
doaj   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine   +17 more
wiley   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy